Jay Venkatesan, See Remarks at Angion Biomedica Corp. (ANGN), bought 69,508 shares at $2.55 ($177K) on 2021-12-16, disclosed to the SEC on 2021-12-20.
Open-market purchase of $177k ANGN by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 27,883 | $71K | 40.1% |
| 2 | $2.55 | 27,883 | $71K | 40.1% |
| 3 | $2.54 | 13,742 | $35K | 19.7% |
| Total | $2.55 avg | 69,508 | $177K | 100% |
| Filing → |
| ANGN | BUY | 2022-05-25 | $101K | — | Filing → |
| ANGN | BUY | 2021-12-29 | $1.5M | — | Filing → |
| ANGN | BUY | 2021-12-22 | $9K | — | Filing → |